The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro.

MA Abou El Hassan, H.M.W. Verheul, AS Jorna, C.G. Schalkwijk, J van Bezu, W.J.F. van der Vijgh

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)
Original languageEnglish
Pages (from-to)357-62
JournalBritish Journal of Cancer
Issue number2
Publication statusPublished - 2003

Cite this